Search

everythinglearnresearchcommunity

for

Search:↓

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Finasteride causes temporary cell death in BPH tissues.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

Finasteride treats hair loss and reduces prostate cancer risk.

Finasteride reduces prostate cancer risk but may increase aggressive cancer risk slightly.

Older men with severe symptoms and larger prostates should focus on prevention, using finasteride and alpha-blockers to manage acute urinary retention.

A new gene mutation causes complete androgen insensitivity in a 16-year-old with a female appearance.

Adrenal tumors can cause high progesterone levels, mimicking symptoms of high cortisol.

Finasteride reduces prostate size and DHT in male mastomys but not in females.

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

Finasteride may help prevent prostate cancer, but more research is needed.

A rare skin cancer caused hair loss and spread, needing multiple treatments.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Blocking testosterone speeds up wound healing in males.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Certain Dibenzo derivatives may help treat prostate cancer.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Early baldness and little chest hair may indicate higher prostate cancer risk.

Cancer prevention has advanced significantly, with some strategies proving successful.